

ROHHAD syndrome: case report of an ultra-rare disease
https://doi.org/10.21508/1027-4065-2025-70-4-84-91
Abstract
ROHHAD is a poorly studied syndrome characterized by multisystem organ involvement and a high mortality rate. According to the literature, approximately 200 cases of this syndrome are known. ROHHAD syndrome has a presumably autoimmune mechanism of disease development, manifested by rapidly developing morbid obesity, hypothalamic dysfunction, apnea, and impaired autonomic regulation. The wide clinical variability of the syndrome complicates timely diagnosis. This article presents a clinical case of a 6-year-old girl with a rare ROHHAD syndrome and to demonstrate a set of the main clinical symptoms and diagnostic signs of the syndrome, as well as possible therapeutic approaches in the management of this life-threatening disease.
About the Authors
M. P. SafonovaRussian Federation
125412, Moscow
O. A. Serebryakova
Russian Federation
117997, Moscow
E. A. Rubtsova
Russian Federation
117997, Moscow
N. M. Zaikova
Russian Federation
125412, Moscow
117997, Moscow
A. N. Podgorny
Russian Federation
125412, Moscow
117997, Moscow
E. A. Potrokhova
Russian Federation
125412, Moscow
References
1. Hampl S.E., Hassink S.G., Skinner A.C., Armstrong S.C., Barlow S.E., Bolling C.F., et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023; 151(2):e2022060640. DOI: 10.1542/peds.2022–060640
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403(10431): 1027–1050. DOI: 10.1016/S0140–6736(23)02750–2
3. Loos R.J.F., Yeo G.S.H. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022; 23(2): 120–133. DOI: 10.1038/s41576–021–00414-z
4. Fishman L.S., Samson J.H., Sperling D.R. Primary alveolar hypoventilation syndrome (Ondine’s curse). Am J Dis Child. 1965; 110(2): 155–161. DOI: 10.1001/archpedi.1965.02090030165011
5. Lazea C., Sur L., Florea M. ROHHAD (Rapid-onset Obesity with Hypoventilation, Hypothalamic Dysfunction, Autonomic Dysregulation) Syndrome-What Every Pediatrician Should Know About the Etiopathogenesis, Diagnosis and Treatment: A Review. Int J Gen Med. 2021; 14: 319–326. DOI: 10.2147/IJGM.S293377
6. Rand C.M., Patwari P.P., Rodikova E.A., Zhou L., BerryKravis E.M., Wilson R.J., et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes. Pediatr Res. 2011; 70(4): 375–378. DOI: 10.1203/PDR.0b013e318229474d
7. Barclay S.F., Rand C.M., Gray P.A., Gibson W.T., Wilson R.J., Berry-Kravis E.M., et al. Absence of mutations in HCRT, HCRTR1 and HCRTR2 in patients with ROHHAD. Respir Physiol Neurobiol. 2016; 221: 59–63. DOI: 10.1016/j.resp.2015.11.002
8. Sartori S., Priante E., Pettenazzo A., Marson P., Suppiej A., Benini F., et al. Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis. J Child Neurol. 2014; 29(3): 421–425. DOI: 10.1177/0883073812469050
9. Grossi A., Rusmini M., Cusano R., Massidda M., Santamaria G., Napoli F., et al. Whole genome sequencing in ROHHAD trios proved inconclusive: what’s beyond? Front Genet. 2023; 14: 1031074. DOI: 10.3389/fgene.2023.1031074
10. Mandel-Brehm C., Benson L.A., Tran B., Kung A.F., Mann S.A., Vazquez S.E., et al. ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD. Ann Neurol. 2022; 92(2): 279–291. DOI: 10.1002/ana.26380
11. Nakamura-Utsunomiya A., Yamaguchi K., Goshima N. AntiZSCAN1 Autoantibodies Are a Feasible Diagnostic Marker for ROHHAD Syndrome Not Associated with a Tumor. Int J Mol Sci. 2024; 25(3): 1794. DOI: 10.3390/ijms25031794
12. Harvengt J., Gernay C., Mastouri M., Farhat N., Lebrethon M.C., Seghaye M.C., et al. ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis. J Clin Endocrinol Metab. 2020; 105(7): dgaa247. DOI: 10.1210/clinem/dgaa247
13. Lazea C., Sur L., Florea M. ROHHAD (Rapid-onset Obesity with Hypoventilation, Hypothalamic Dysfunction, Autonomic Dysregulation) Syndrome-What Every Pediatrician Should Know About the Etiopathogenesis, Diagnosis and Treatment: A Review. Int J Gen Med. 2021; 14: 319–326. DOI: 10.2147/IJGM.S293377
14. Prokopev G.G., Abidova M.M., Postnikova E.V., Shorina M.Yu., Mihajlova A.D., Zhilina S.S., Sulejmanov A.B., Medvedev A.I., Krapivkin A.I. Diagnostic criteria and effective treatment strategies for respiratory failure in children with ROHHAD-syndrome. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2025; 70(2/2): 65-73. (in Russ.)] DOI:10.21508/1027-4065-2025-70-2(p.2)-65-73-
15. Trang H., Samuels M., Ceccherini I., Frerick M., GarciaTeresa M.A., Peters J., et al. Guidelines for diagnosis and management of congenital central hypoventilation syndrome. Orphanet J Rare Dis. 2020; 15(1): 252. DOI: 10.1186/s13023–020–01460–2
Review
For citations:
Safonova M.P., Serebryakova O.A., Rubtsova E.A., Zaikova N.M., Podgorny A.N., Potrokhova E.A. ROHHAD syndrome: case report of an ultra-rare disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2025;70(4):84–91. (In Russ.) https://doi.org/10.21508/1027-4065-2025-70-4-84-91